Skip to Main Content
Mental Health & Behavioral Research, Phase Pilot

Dysregulation in mGluR5 as a marker of BPD and suicide related endophenotypes

What is the purpose of this trial?

This study involves the use of brain imaging (MRI and PET) to investigate a potential novel intervention target in borderline personality disorder. Participation in this study begins with a short confidential phone interview and an in-person visit for psychological and medical screening (which includes blood work and a urine drug test). All information provided is confidential. If you meet study criteria, you will be asked to return for one MRI scan and one PET scan. You will also be asked to perform some tests on a computer to assess cognitive functions such as memory and decision-making. You will be paid for each procedure you take part in.

  • Trial with
    National Institute of Mental Health (NIMH)
  • Ages
    18 years - 65 years
  • Gender
    Both

Contact Information

For more information about this study, including how to volunteer, contact Ashley Wagner

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    10/17/2024
  • Study HIC
    #2000023168